-+ 0.00%
-+ 0.00%
-+ 0.00%

SELLAS Life Sciences Gr Q3 EPS $(0.05), Inline

Benzinga·11/13/2026 12:58:23
Listen to the news
SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year.